Guy Jerusalem
Overview
Explore the profile of Guy Jerusalem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
6150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Derouane F, Ambroise J, van Marcke C, Van Bockstal M, Berliere M, Galant C, et al.
Mol Oncol
. 2025 Feb;
PMID: 39912409
Epithelial-mesenchymal transition (EMT) and tumor-infiltrating lymphocytes (TILs) play a central role in early-stage breast cancer (BC) and are associated with chemoresistance, stemness, and invasion. The objective of this study was...
2.
Lardinois C, Bleret V, Danthine D, Lifrange E, Jerusalem G, Cusumano P
Rev Med Liege
. 2025 Jan;
80(1):42-47.
PMID: 39815704
Breast cancer is a complex disease influenced by genetic and environmental factors. Molecular profiling research has revealed significant diversity within the disease, including among tumours with similar morphological features. This...
3.
Pottier C, Montero-Ruiz L, Jehay R, Wery C, Baiwir D, Mazzucchelli G, et al.
Cancer Commun (Lond)
. 2025 Jan;
PMID: 39801257
No abstract available.
4.
Lopez J, Powles T, Braiteh F, Siu L, LoRusso P, Friedman C, et al.
Nat Med
. 2025 Jan;
31(1):152-164.
PMID: 39762422
Effective targeting of somatic cancer mutations to enhance the efficacy of cancer immunotherapy requires an individualized approach. Autogene cevumeran is a uridine messenger RNA lipoplex-based individualized neoantigen-specific immunotherapy designed from...
5.
Harbeck N, Ciruelos E, Jerusalem G, Muller V, Niikura N, Viale G, et al.
Nat Med
. 2024 Dec;
30(12):3780.
PMID: 39653780
No abstract available.
6.
Delvenne M, Bonhivers V, Seidel L, Delvenne P, Duysinx B, Jerusalem G, et al.
Rev Med Liege
. 2024 Nov;
79(11):701-710.
PMID: 39545530
This retrospective study including 93 patients who presented a new diagnosis of lung cancer at the University Hospital of Liege between January 2023 and April 2023 analyzed the prevalence of...
7.
Baussard L, Ernst M, Diep A, Jerusalem G, Vanhaudenhuyse A, Marie N, et al.
Cancer Med
. 2024 Oct;
13(19):e70268.
PMID: 39387227
Background: Understanding cancer symptom cluster through network analyses is a new approach in oncology, revealing interconnected and influential relationships among reported symptoms. We aimed to assess these relationships using network...
8.
Harbeck N, Ciruelos E, Jerusalem G, Muller V, Niikura N, Viale G, et al.
Nat Med
. 2024 Sep;
30(12):3717-3727.
PMID: 39271844
Trastuzumab deruxtecan (T-DXd) intracranial activity has been observed in small or retrospective patient cohorts with human epidermal growth factor receptor 2-positive (HER2) advanced/metastatic breast cancer (mBC) and stable or active...
9.
Streel S, Louis R, Jerusalem G
Rev Med Liege
. 2024 Jun;
79(5-6):364-371.
PMID: 38869125
The observation is unequivocal: nearly half of cancer deaths could be avoided ! This statement, both alarming and hopeful, underscores the crucial importance of preventive measures in the fight against...
10.
Bonhivers V, Delvenne M, Delvaux M, Petitjean V, Le Jeune L, Englebert E, et al.
Rev Med Liege
. 2024 Jun;
79(5-6):352-356.
PMID: 38869123
Responsible for a significant morbidity and mortality, smoking remains a major public health issue. Smoking cessation clinics are an integral part of the fight against smoking. This retrospective study, carried...